The Future of Health Starts at Birth.
At RAIOA, we believe your placenta isn’t just part of your past—it’s a powerful investment in your future health. When a placenta is preserved after childbirth, we’re able to extract fetal mesenchymal stem cells (MSCs)—some of the most potent regenerative cells known to science. These mesenchymal cells are unique in that they can differentiate into virtually any type of tissue in the body, from muscle and cartilage to nerve and organ cells. Their flexibility makes them a groundbreaking tool in both regenerative medicine and the future of anti-aging therapies.
Mesenchymal Cells
Unmatched Potency
Fetal mesenchymal stem cells, particularly those derived from the placenta and umbilical cord, are younger, more adaptive, and have higher regenerative potential than adult stem cells.
Versatile Applications:
These cells are being studied for their role in:
-
Repairing damaged tissues and organs
-
Managing autoimmune conditions
-
Reversing degenerative diseases
-
Enhancing longevity and biological youthfulness
Future-Ready:
With the pace of innovation in bioprinting and cell therapy, preserving these cells today opens the door to future treatments that don’t even exist yet—like lab-printed organs using your own cellular blueprint.
Exosomes Are Messengers, Not Waste
For decades, exosomes were thought to be cellular “trash”. Modern research, however, shows that they carry mRNA, proteins, and microRNAs capable of reprogramming other cells. They’re now recognized as critical communication vehicles for healing and regeneration. Banking placenta MSCs preserves the very cells that release the most potent, youthful exosomes. Unlike stem cells, which are limited by the possibility of cell rejection, exosomes lack immune antigens; they can circulate without triggering rejection. With UrExo | UrMSCs, families are banking the resources that could one day serve as personalized exosomes, avoiding the risks of foreign grafts. They are already being used in clinics for pain, injury, stroke recovery, and immune modulation, with numerous other applications under review for the future.
Our Services
Ur.Exo | Ur.MSCs is RAIOA’s advanced placenta banking service. We collect and preserve the fetal side of the placenta, isolate mesenchymal stem cells (MSCs), and store small amniotic membrane grafts. These resources may support healing for wounds, burns, and chronic conditions, while keeping the door open to future regenerative therapies.
Why Placenta Banking vs. Cord Blood Banking?
Most companies focus only on cord blood, which contains hematopoietic stem cells used in blood disorders. Placenta tissue, however, is rich in mesenchymal stem cells (MSCs)—younger, more adaptable cells with regenerative and immunomodulatory potential.
What We Bank
-
Placenta-Derived MSCs: The most potent stem cells for regenerative potential.
-
Amniotic Membrane Micro-Grafts: Biologic grafts shown to support wound healing and burns.
-
Foundation for Exosomes: Stored MSCs may later provide autologous exosomes as therapies evolve.
Who can use it?
- Your child: Best match, full compatibility.
- Parents and siblings: Possible under physician guidance.
- Future generations: Preserving today may extend benefits beyond one lifetime.
Neurological
Exosomes are small enough to cross or hitchhike across the blood–brain barrier, delivering signals to damaged neurons. Research highlights improvements in stroke recovery, neuropathy, Bell’s palsy, and nerve injuries. MicroRNAs inside exosomes can promote axon sprouting and re-myelination, supporting regeneration once thought impossible.*
Musculoskeletal Healing
Exosomes and MSCs can support repair in meniscus tears, rotator cuff injuries, tendinopathy, and cartilage degeneration. By delivering microRNAs and proteins, they “wake up” local stem cells to restart repair in tissues with poor blood supply. Clinical experience shows faster recovery, less pain, and improved function compared to conventional options.*
Cardiac Repair
Preclinical studies show exosomes may reduce damage after heart attacks by protecting and regenerating heart muscle cells. By modulating inflammation and supporting blood vessel repair, they improve recovery potential. While still under research, this is a major frontier of regenerative cardiology.*
Wound + Burn Care
Amniotic membrane and placenta-derived MSCs are already being used as biologic dressings. They can accelerate healing of diabetic ulcers, burns, and chronic wounds by supporting new tissue growth and reducing scarring. Banking ensures your family’s access to these natural grafts.*
Immune & Inflammatory Support
Exosomes help reprogram the immune system from chronic inflammation to regeneration. This has shown promise in conditions like autoimmune pain and gout, where patients experienced faster resolution with less collateral damage. Research continues into their role in slowing immune aging.*
Fertility & Reproductive Health
Placenta-derived MSCs and exosomes are under study for improving the uterine lining, ovarian function, and implantation success. They may help optimize fertility treatments and reduce inflammation in reproductive tissues. UR-EXO banking preserves these options for future reproductive health needs.*
Skin & Aesthetic Regeneration
Exosomes are being investigated for skin repair, anti-aging, and hair restoration. Their ability to stimulate collagen, reduce inflammation, and encourage follicle activity makes them a natural fit for aesthetic medicine. Preserving MSCs today may provide future personalized beauty and skin therapies.*
Orthopedic & Sports Recovery
Athletes and active individuals are turning to MSCs and exosomes to speed recovery from ligament tears, joint injuries, and overuse syndromes. By reducing inflammation and stimulating repair, they can shorten downtime. These applications align with the future of sports medicine.*
Future Potential
Exosome science is less than 20 years old, but advancing rapidly. Emerging research explores uses in neurology, cardiology, oncology, and longevity medicine. Banking placenta MSCs now ensures your family has access to personalized regenerative tools as these breakthroughs mature.*
*All described applications of MSCs and exosomes are considered experimental, with research ongoing and no guarantees of safety or effectiveness.
Unlike many companies that use heat dehydration, which destroys proteins and denatures vital bioactive compounds, RAIOA uses freeze-drying (lyophilization). This process helps preserve more of the placenta’s natural proteins, hormones, and micronutrients, creating a higher-quality capsule.
We exceed regulatory requirements with:
• Two days of back-to-back microbiological testing.
• ≥14-day sterility incubation.
• Mycoplasma and endotoxin screening.
• Antibiotic wash validation.
Frequently Asked Questions
Are MSCs “stem cells that can turn into any cell”?
They are multipotent (not totipotent/pluripotent). MSCs can differentiate into multiple mesenchymal lineages (bone, cartilage, fat, etc.) and act via paracrine immunomodulatory signaling—a major reason they’re under study.
How long can cells be stored?
Cryopreservation preserves viability/function when validated protocols are used; long-term storage is standard for perinatal tissues. Exact usable lifetime depends on storage conditions and future testing at thaw.
Can “anyone in the family” use it?
Autologous (your child) is most straightforward. Related use for parents/siblings may be possible under physician guidance, but compatibility, indication, and regulations apply.
Do you wash out antibiotics after decontamination?
Yes. Residuals can mask contaminant growth; our process includes validated antibiotic washout before sterility testing.
Is exosome therapy available now?
In the U.S., exosome products are not FDA-approved; access is limited to research or approved trials. We bank tissues now to preserve future options as regulations and evidence evolve.
Get In Touch
Connect With RAIOA — Your Future Starts Here
